Rebecca A. Wright

Altered proliferation and networks in neural cells derived from idiopathic autistic individuals

Maria C. Marchetto, Haim Belinson, Yuan Tian et al. · Molecular Psychiatry · 2016 · 482 citations · Full text

Neural Cells, Developmental Biology, Syndromic Autism +7

Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740):  A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties

James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1997 · 392 citations

Pharmacological Characterization, Active Group 2, Psychotropic Medication +16

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

Anne Kingston, Paul L. Ornstein, Rebecca A. Wright et al. · Neuropharmacology · 1998 · 364 citations

Functional Selectivity, Medicine, Drug Discovery +7

Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs

Amy L. Firth, Tushar Menon, Gregory S. Parker et al. · Cell Reports · 2015 · 318 citations · Full text

Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740):  Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors

James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1999 · 286 citations · Full text

Active Agonists, Mglu Receptors, Pharmacotherapy +16